Pharma 4.0 Global Market Report 2024

Description

Pharma 4.0, also termed Pharmaceutical 4.0, signifies the integration of advanced digital technologies within the pharmaceutical sector, akin to the broader concept of Industry 4.0. It represents a transformative approach to pharmaceutical manufacturing and healthcare delivery, aimed at addressing challenges such as rising costs, regulatory compliance, drug shortages, and the demand for personalized treatments. Moreover, it aims to unlock new avenues for innovation while enhancing patient care.

The primary components of Pharma 4.0 include hardware, software, and services. Hardware refers to the physical components of computer systems or electronic devices, encompassing elements such as processors, memory, storage, and peripherals. Various cutting-edge technologies, including cloud computing, artificial intelligence (AI), big data analytics, and the Internet of Things (IoT), are leveraged across numerous applications within the pharmaceutical sector, ranging from drug discovery and development to clinical trials and manufacturing processes. Pharma 4.0 solutions find application across a diverse range of end-users, primarily including pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and contract manufacturing organizations (CMOs).

The pharma 4.0 market research report is one of a series of new reports from The Business Research Company that provides pharma 4.0 market statistics, including pharma 4.0 industry global market size, regional shares, competitors with a pharma 4.0 market share, detailed pharma 4.0 market segments, market trends and opportunities, and any further data you may need to thrive in the pharma 4.0 industry. This pharma 4.0 market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharma 4.0 market size has grown exponentially in recent years. It will grow from $14.92 billion in 2023 to $17.99 billion in 2024 at a compound annual growth rate (CAGR) of 20.5%. The growth observed during the historic period can be attributed to several factors. These include adherence to regulatory compliance and quality assurance standards, the expiration of drug patents leading to increased generic competition, rising healthcare expenditure trends, growing demand for personalized medicine and biologics, as well as the globalization of pharmaceutical markets.

The pharma 4.0 market size is expected to see exponential growth in the next few years. It will grow to $38.44 billion in 2028 at a compound annual growth rate (CAGR) of 20.9%. The projected growth in the forecast period can be attributed to several key factors. These include a shift towards value-based healthcare models, driven by an aging population and increased healthcare needs, growing demand for personalized medicine and precision therapeutics, regulatory reforms and changes in healthcare policies, as well as a growing emphasis on patient-centric care and outcomes. Major trends expected during this period include advancements in personalized medicine and precision therapeutics, the adoption of digital health technologies, the implementation of value-based healthcare models, regulatory harmonization and accelerated approval processes, and the digitization and enhanced transparency of the supply chain.

The expansion of telemedicine and remote patient monitoring is poised to drive the growth of the pharma 4.0 market. Telemedicine, involving the remote provision of medical care and consultation using telecommunications technology, and remote patient monitoring, which entails the collection, transmission, and analysis of patient health data from a distance, are witnessing rapid expansion driven by technological advancements, increasing demand for convenient healthcare access, and the necessity for efficient management of chronic conditions. These practices play crucial roles in pharma 4.0, fostering patient-centered care, enabling real-time data collection for personalized medicine, and empowering pharmaceutical companies to gather valuable patient insights for drug development. For instance, data from Statistics Canada in November 2022 indicated that a significant portion of healthcare workers in Canada (24%) provided remote healthcare services since March 2020, predominantly through phone consultations and video calls. Additionally, according to the Centers for Disease Control and Prevention in October 2022, telemedicine was utilized by 37.0% of individuals in 2021, demonstrating its increasing prevalence across different demographics. This expansion of telemedicine and remote patient monitoring underscores their pivotal role in driving the growth of the pharma 4.0 market.

Key players in the pharma 4.0 market are leveraging innovative technologies such as cloud-based drug discovery platforms to gain a competitive edge. Platforms such as StarDrop offer researchers and pharmaceutical companies cloud-hosted environments accessible via the Internet, enabling various drug discovery activities such as compound screening, molecular modeling, and data analysis. For example, Optibrium Ltd. launched a cloud-based version of its renowned drug discovery platform, StarDrop, in October 2023. This cloud-based deployment enhances accessibility and reduces total ownership costs while retaining all functionalities of the desktop application. Hosted on Amazon Web Services (AWS) and supported by Optibrium's ISO 27001-accredited information security system, the platform ensures advanced data security, including encryption for secure data transfer and protection behind a firewall.

In June 2022, ProductLife Group bolstered its presence in the pharma 4.0 market through the acquisition of Pharma IT ApS. This strategic move aims to enhance ProductLife Group's market position, particularly in Northern Europe, and expand its service offerings in life sciences digitalization. Pharma IT ApS, a Denmark-based consulting company specializing in life sciences, brings valuable expertise in consulting services for the medical device, biotech, and pharmaceutical industries, strengthening ProductLife Group's capabilities in catering to the evolving needs of the pharma 4.0 landscape.

Major companies operating in the pharma 4.0 market are Alphabet Inc., Microsoft Corporation, Pfizer Inc., Johnson & Johnson, Amazon Web Services Inc., Roche Holding AG, International Business Machines Corporation, Merck & Co. Inc., Cisco Systems Inc., Bristol Myers Squibb Company, Oracle Corporation, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc, Honeywell International Inc., Fujitsu Limited, ABB Ltd., Siemens Healthineers, GE Healthcare, Lotte Corporation, SAS Institute Inc., Optum Inc., POLARISqb, Syntekabio, Optibrium

North America was the largest region in the pharma 4.0 market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma 4.0 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharma 4.0 market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharma 4.0 market consists of revenues earned by entities by providing services such as remote patient monitoring, virtual consultations, digital therapeutics, and medication adherence programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The Pharma 4.0 market also includes sales of digital twin platforms, smart manufacturing systems, patient engagement tools, and monitoring tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Including: 1) By Component: Hardware; Software; Services
2) By Technology: Cloud Computing; Artificial Intelligence (Al); Big Data Analytics; Internet of Things (IoT)
3) By Application: Drug Discovery And Development; Clinical Trials; Manufacturing
4) By End-User: Pharmaceutical Companies; Biotechnology Companies; Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)
Covering: Alphabet Inc.; Microsoft Corporation; Pfizer Inc.; Johnson & Johnson; Amazon Web Services Inc.

Product Code: r17414

1. Executive Summary

2. Pharma 4.0 Market Characteristics

3. Pharma 4.0 Market Trends And Strategies

4. Pharma 4.0 Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Pharma 4.0 Market Size and Growth

5.1. Global Pharma 4.0 Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Pharma 4.0 Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Pharma 4.0 Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharma 4.0 Market Segmentation

6.1. Global Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hardware
Software
Services
6.2. Global Pharma 4.0 Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cloud Computing
Artificial Intelligence (Al)
Big Data Analytics
Internet of Things (IoT)
6.3. Global Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Drug Discovery And Development
Clinical Trials
Manufacturing
6.4. Global Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)

7. Pharma 4.0 Market Regional And Country Analysis

7.1. Global Pharma 4.0 Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pharma 4.0 Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharma 4.0 Market

8.1. Asia-Pacific Pharma 4.0 Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharma 4.0 Market

9.1. China Pharma 4.0 Market Overview
9.2. China Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharma 4.0 Market

10.1. India Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharma 4.0 Market

11.1. Japan Pharma 4.0 Market Overview
11.2. Japan Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharma 4.0 Market

12.1. Australia Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharma 4.0 Market

13.1. Indonesia Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharma 4.0 Market

14.1. South Korea Pharma 4.0 Market Overview
14.2. South Korea Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharma 4.0 Market

15.1. Western Europe Pharma 4.0 Market Overview
15.2. Western Europe Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharma 4.0 Market

16.1. UK Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharma 4.0 Market

17.1. Germany Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharma 4.0 Market

18.1. France Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharma 4.0 Market

19.1. Italy Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharma 4.0 Market

20.1. Spain Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharma 4.0 Market

21.1. Eastern Europe Pharma 4.0 Market Overview
21.2. Eastern Europe Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharma 4.0 Market

22.1. Russia Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharma 4.0 Market

23.1. North America Pharma 4.0 Market Overview
23.2. North America Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharma 4.0 Market

24.1. USA Pharma 4.0 Market Overview
24.2. USA Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharma 4.0 Market

25.1. Canada Pharma 4.0 Market Overview
25.2. Canada Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharma 4.0 Market

26.1. South America Pharma 4.0 Market Overview
26.2. South America Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharma 4.0 Market

27.1. Brazil Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharma 4.0 Market

28.1. Middle East Pharma 4.0 Market Overview
28.2. Middle East Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharma 4.0 Market

29.1. Africa Pharma 4.0 Market Overview
29.2. Africa Pharma 4.0 Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Pharma 4.0 Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Pharma 4.0 Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharma 4.0 Market Competitive Landscape And Company Profiles

30.1. Pharma 4.0 Market Competitive Landscape
30.2. Pharma 4.0 Market Company Profiles
- 30.2.1. Alphabet Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Microsoft Corporation
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Pfizer Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Johnson & Johnson
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Amazon Web Services Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Pharma 4.0 Market Other Major And Innovative Companies

31.1. Roche Holding AG
31.2. International Business Machines Corporation
31.3. Merck & Co. Inc.
31.4. Cisco Systems Inc.
31.5. Bristol Myers Squibb Company
31.6. Oracle Corporation
31.7. AstraZeneca PLC
31.8. Novartis International AG
31.9. GlaxoSmithKline plc
31.10. Honeywell International Inc.
31.11. Fujitsu Limited
31.12. ABB Ltd.
31.13. Siemens Healthineers
31.14. GE Healthcare
31.15. Lotte Corporation

32. Global Pharma 4.0 Market Competitive Benchmarking

33. Global Pharma 4.0 Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharma 4.0 Market

35. Pharma 4.0 Market Future Outlook and Potential Analysis

35.1 Pharma 4.0 Market In 2028 - Countries Offering Most New Opportunities
35.2 Pharma 4.0 Market In 2028 - Segments Offering Most New Opportunities
35.3 Pharma 4.0 Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer